Remko Prevo

Old Road Campus Research Building, Roosevelt Drive
Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models.

Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models.

Journal: Cell death & disease

Published: September 17, 2023

Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models.

Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 27, 2022

Automated 96-well format high throughput colony formation assay for siRNA library screen.

Automated 96-well format high throughput colony formation assay for siRNA library screen.

Journal: STAR protocols

Published: May 11, 2022

Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance.

Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance.

Journal: Nature communications

Published: March 17, 2021

Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer.

Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 29, 2020

The anti-malarial drug atovaquone potentiates platinum-mediated cancer cell death by increasing oxidative stress.

The anti-malarial drug atovaquone potentiates platinum-mediated cancer cell death by increasing oxidative stress.

Journal: Cell death discovery

Published: August 01, 2020

External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increase.

External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increase.

Journal: Cancers

Published: February 15, 2020

Targeting TOPK sensitises tumour cells to radiation-induced damage by enhancing replication stress.

Targeting TOPK sensitises tumour cells to radiation-induced damage by enhancing replication stress.

Journal: Cell death and differentiation

Published: November 28, 2019

Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma.

Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 18, 2019

Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy.

Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy.

Journal: The Prostate

Published: December 21, 2018

T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics.

T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics.

Journal: Cell death & disease

Published: August 03, 2018

CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent manner.

CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent manner.

Journal: Cell cycle (Georgetown, Tex.)

Published: July 27, 2018

Showing 1-12 of 21

Last Updated: 09/26/2026